Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer

Overview of attention for article published in Frontiers in Cell and Developmental Biology, June 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 1 X post from an account with 3,907 followers.

New Research: Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer: Triple-negative breast cancer (TNBC) is highly aggressive and does not express estrogen receptor (ER), progesterone… #celldevbio http

29 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.